A summary of technoloyg projects, showing process is key to technology commercialization. In this summary, we demonstrate our ability to commercialization technologies in biotech, medical, consumer, materials, science, and other fields.

1. Our Qualifications
We are consultants who were associated with IC2 Institute at The University of Texas at
Austin with experience in running commercialization programs worldwide. For each
program, we were responsible for the development of an infrastructure within the country
to manage the commercialization process.
The process included, as a first step, developing a local partner who would be responsible
for finding and performing an initial evaluation of a large group of technologies submitted
for evaluation.
The next step was the evaluation of the technologies by commercialization specialists
whose responsibility was to perform an initial evaluation.
The third step was the management of a training program for selected innovators to teach
them globalization. This training program included global marketing techniques, patent
strategies, process to enter new markets, technology evaluation processes, and local
business techniques.
For a selected group of innovators, a more detailed commercialization plan was developed,
with discussions with key industry players and a plan for entering new markets in the
United States and elsewhere.
Finally, for the technologies which were ready, business development processes were run
resulting in engagement agreements for sales, licensing, or testing / evaluation of the
technologies. The specific agreement was catered toward what was defined as the next
step for the technology.
To successfully conclude business development worldwide, we developed a global network
of decision makers for new technologies in multiple areas, including life science, material
science, biotechnology, information technology, consumer goods, and other areas and
successfully conducted evaluation, training, and business development for our clients with
these partners. These partners were engaged in making the programs listed below
successful.
 In Hungary, we managed two one year programs in which we reviewed up to 200
technologies each year, completed training programs in entrepreneurship, and
developed over ten engagement agreements each year for key technologies to enter
worldwide markets.
 In the India DST program, we managed four one year programs in which we
reviewed up to 250 technologies each year, completed training programs in
entrepreneurship in multiple cities, and developed over twelve engagement
agreements each year for key technologies to enter worldwide markets.

2.  In the India DRDO program, we managed a one year pilot program in which we
reviewed over 200 technologies and, along with our India partners, developed over
thirty engagement agreements within India and worldwide agreements for key
technologies.
 In Mexico, we conducted business development efforts in several one year projects
and developed engagement agreements each year for key technologies to enter
worldwide markets.
 In Korea, we conducted business development efforts in several one year projects
and developed engagement agreements each year for key technologies to enter
worldwide markets.

3. Technology Commercialization Training and Business Development Structure
We believe a combination of remote training, onsite training, and business development
programs provide the best opportunities for economic growth for countries. Here is an
outline of a proposed training program.
Webinars – To maximize the onsite training, the webinars should be conducted to prepare
them for the training and the evaluation of the technology. In the webinars, we will cover
topics such as team analysis, competitors, markets, IP analysis and development of a
product description. These webinars will be conducted in short (1.5 -2 hour) sessions with
assignments for the innovators to complete. We will record these sessions for viewing at a
later date and time for innovators who were unable to attend the live session. We will
review the innovators assignments and provide feedback before the training classes. With
the webinars, the innovators can begin to plan for market entry for their technologies,
understand the basic concepts, and have a direction for their technology in advance of the
onsite training. With advance training, the innovators will be able to maximize their time
and efforts in the onsite training.
On Site Training – The onsite training will be two full days. The subject matter will
include commercialization strategies, planning, US market analysis, and planning. Because
of the earlier training, the subject matter and questions will be focused on their
technologies and the innovators will be more prepared for the class and have more
advanced questions. Panidea will staff these sessions with two senior consultants who
have extensive experience in the evaluation and commercialization of new technologies
and are familiar with worldwide markets and can assist the innovators in the process of
market entry in sales, licensing, distribution or funding.
Business Development – After the course, we will be able to provide a market validation
summary of the technology, where we can provide initial recommendations for direction
for the innovators, even if it would be to hold back on market entry in the immediate
term. For selected technologies, we would propose a business development process for
market entry. This process can be based upon individual technologies or a program for a
group of technologies. It is critical for your organization to find a partner who can provide
this service post training. The discussions, answers, and work by the innovators will be
lost unless your training partner can deliver on this key follow up to the onsite training.

4. Technology Commercialization Project: iMFAST
This is one of a series of projects completed by Panidea consultants while employed with the IC2 Institute at
The University of Texas at Austin. The program structure was generally six months of technology evaluation,
where the list of options was reduced from several hundred to a viable 12 – 15 technologies selected for
business development. In the second six months, we were responsible for taking the innovation to the
marketplace, identifying key partners, establishing relationships with these organizations and the key staff,
and getting engagement agreements signed by both the company and the innovator to advance the
technology in the marketplace. Given the program structure, these contacts were identified, relationships
established, and agreement signed within the program timeframes.
The key aspect to the process was in the ongoing development of relationships to bring the product to the
marketplace. These contacts validated the technology as well and became customers as part of the process.
iMFAST, is a platform to enable banks to offer financial services to villagers in rural areas. The system
includes a transportable computing device that can guide a villager through banking transactions in their
local language. The system handles customer identification, data capture, data transmission and while it has
been designed for financial services, these core capabilities could be used in e-governance and other verticals
as well.
There are design prototypes for customer demos and a pilot program for Corporation Bank began on March
8th, 2007. Kasgatta is a village of 240 homes that is roughly 5 miles away from the closest Corporation Bank
branch and about 40 miles outside of Bangalore. As of May 2007, they have created 105 accounts with the
assistance of Shreeshakthi, a self-help group, who is being paid a nominal fee by Corporation Bank.

5. Technology Commercialization Project: Logical Medical Systems
This is one of a series of projects completed by Panidea consultants while employed with the IC2 Institute at
The University of Texas at Austin. The program structure was generally six months of technology evaluation,
where the list of options was reduced from several hundred to a viable 12 – 15 technologies selected for
business development. In the second six months, we were responsible for taking the innovation to the
marketplace, identifying key partners, establishing relationships with these organizations and the key staff,
and getting engagement agreements signed by both the company and the innovator to advance the
technology in the marketplace. Given the program structure, these contacts were identified, relationships
established, and agreement signed within the program timeframes.
The key aspect to the process was in the ongoing development of relationships to bring the product to the
marketplace. These contacts validated the technology as well and became customers as part of the process.
The technology is an Artificial Intelligence (AI) software system that helps automate the diagnosis of diseases
in human patients. It was created by Logical Medical Systems out of India. The technology seeks to improve
the accuracy of patient diagnosis and treatment. It identifies over 1700 diseases and is more robust overall
than any other system on the market now. Its’ application architecture, while well suited with some changes
to smaller offices, will require fairly sizable enhancements to be accepted in a large enterprise. It’s AI engine
is based on Bayesian methods that only work accurately on complex diseases with numerous symptoms
(features). It also does not support intuitive “reflexive questioning” that adapts the questions asked based on
responses received. Further, the system only does rudimentary text file loads of patient history and lab
results. It will therefore not easily integrate with existing electronic medical records systems for real time
data. These issues will make the system cumbersome to use by practitioners during the examination. The
inventor has not done any formal independent validation testing to prove the accuracy of the diagnosis. The
system is almost fully built out and has been used by its inventor now for several years.

6. Technology 084: DEPA Multi Insect Repellent
Technology Commercialization Project: DEPA Multi Insect Repellent
This is one of a series of projects completed by Panidea consultants while employed with the IC2 Institute at
The University of Texas at Austin. The program structure was generally six months of technology evaluation,
where the list of options was reduced from several hundred to a viable 12 – 15 technologies selected for
business development. In the second six months, we were responsible for taking the innovation to the
marketplace, identifying key partners, establishing relationships with these organizations and the key staff,
and getting engagement agreements signed by both the company and the innovator to advance the
technology in the marketplace. Given the program structure, these contacts were identified, relationships
established, and agreement signed within the program timeframes.
The key aspect to the process was in the ongoing development of relationships to bring the product to the
marketplace. These contacts validated the technology as well and became customers as part of the process.
Insects are carriers (vectors) of dreaded diseases such as malaria and dengue. Various methods have been
used for the control of these vectors in different ecological conditions with certain limitations. Because of the
unavailability of m-toluic acid in India for the manufacture of N,N-diethyl m-toluamide (DEET), there is a
need to develop an alternate effective and safe insect repellent.
Defence Research and Development Organization (DRDO) has developed a multi-insect repellent DEPA
(diethylphenylacetamide) cream formulation. Extensive studies have been carried out for its bio-efficacy and
toxicity including inhalation. No untoward effect on mammalian systems has been observed. The cream
formulation has been accepted and recommended by the Director General Armed Forces Medical Services
(DGAFMS).
The active ingredient in many commercially available products is diethyl toluamide, popularly known as
DEET, the world''s most extensively used protection against mosquito and other insect bites.

7. Technology K2120 – Reliability and Durability Testing System
Technology Commercialization Project: Reliability and Durability Testing System
This is one of a series of projects completed by Panidea consultants while employed with the IC2 Institute at
The University of Texas at Austin. The program structure was generally six months of technology evaluation,
where the list of options was reduced from several hundred to a viable 12 – 15 technologies selected for
business development. In the second six months, we were responsible for taking the innovation to the
marketplace, identifying key partners, establishing relationships with these organizations and the key staff,
and getting engagement agreements signed by both the company and the innovator to advance the
technology in the marketplace. Given the program structure, these contacts were identified, relationships
established, and agreement signed within the program timeframes.
The key aspect to the process was in the ongoing development of relationships to bring the product to the
marketplace. These contacts validated the technology as well and became customers as part of the process.
KNR is a company in the space of Reliability and Durability Testing Systems and is focused upon advancing
material, component and structure testing technical services. The company manufactures test equipment for
sale as well as offering testing services as a separate revenue stream. The company offers its products and
services in six different industry segments. They have developed a portfolio of customized testing equipment
and simulations technology that is used in a variety of industries such as Automotive, Transportation, Civil
Engineering, Energy, Robotics, and Material.
KNR has three divisions:
(1) Testing System Manufacturing
 Develop and build standard testing systems and turn-key test systems
(2) Testing Service Business for Automobile, Railroad and Civil Engineering
 Testing system operation; testing data reporting and analysis; engineering support;
turnkey management; R&D collaboration (Automotive, Train Testing and Civil
Engineering Laboratories)
(3) Research and Development
 World class R&D center
 Cooperative network global research centers
 Continued development new test technology; upgrade major components.
KNR has its own R&D center and manufacturing line in its facility which the company believes is a major
reason it has done so well in the equipment testing market in its home country.

8. Technology Commercialization Project: Gravity Recommendation Engine
This is one of a series of projects completed by Panidea consultants while employed with the IC2 Institute at
The University of Texas at Austin. The program structure was generally six months of technology evaluation,
where the list of options was reduced from several hundred to a viable 12 – 15 technologies selected for
business development. In the second six months, we were responsible for taking the innovation to the
marketplace, identifying key partners, establishing relationships with these organizations and the key staff,
and getting engagement agreements signed by both the company and the innovator to advance the
technology in the marketplace. Given the program structure, these contacts were identified, relationships
established, and agreement signed within the program timeframes.
The key aspect to the process was in the ongoing development of relationships to bring the product to the
marketplace. These contacts validated the technology as well and became customers as part of the process.
Gravity Reco Web Services has devised a recommendation agent that is offered as Web-based or standalone
service to e-commerce companies, or those companies that offer an e-commerce Web site or other services
that might provide customized content to consumers. A recommendation agent is a computer-based program
that recommends items to users based on a set of pre-determined criteria, with the purpose of creating more
sales for the e-commerce site and increasing customer satisfaction with the site by providing personalized,
customized choices that better fit the needs of the customer.
Gravity Reco Web Services has entered the prestigious Netflix Competition and is currently within the top 5
best competitors, and has ranked as high as second place. According to Neflix, the prize is offered to the first
company that can demonstrate 10% better accuracy than what their Cinematch technology can do on the
same training data set – accuracy is a measurement of how closely predicted ratings of movies match
subsequent actual ratings. However, many of the top recommendation agent developers have chosen not to
participate in the contest, leaving the competition to mostly academics. This taints the results somewhat as it
is hard to determine how Gravity Recon would perform against the market leaders

9. Technology Commercialization Project: ClimaGear
This is one of a series of projects completed by Panidea consultants while employed with the IC2 Institute at
The University of Texas at Austin. The program structure was generally six months of technology evaluation,
where the list of options was reduced from several hundred to a viable 12 – 15 technologies selected for
business development. In the second six months, we were responsible for taking the innovation to the
marketplace, identifying key partners, establishing relationships with these organizations and the key staff,
and getting engagement agreements signed by both the company and the innovator to advance the
technology in the marketplace. Given the program structure, these contacts were identified, relationships
established, and agreement signed within the program timeframes.
The key aspect to the process was in the ongoing development of relationships to bring the product to the
marketplace. These contacts validated the technology as well and became customers as part of the process.
“The technology which is the subject of this report, ClimaGear is a temperature regulating apparel technology
that aids in the comfort of outdoor workers/enthusiasts and military personnel. By allowing users to choose
the temperature that comforts them, they are able to remain in their harsh environment without adding
stress, discomfort, health problems, or lost productivity. It was developed by Kranthi Vistakula while
attending MIT.
ClimaGear was developed to offer users a source of comfort in differing hot or cold climates. Mr. Vistakula
plans to implement ClimaGear into many types of apparel, including coats, jackets, pants, and helmets. A
battery operated prototype jacket with 20 cooling/heating points on the torso and arms has been developed
that is capable of removing 50W of heat. It is mobile, quiet, lightweight, failure tolerant, easy to use, with no
moving parts.
He has received a DSIR grant and incubator space from FIIT Delhi. A PCT full utility patent was issued with
priority dating of February 23rd, 2007. All intellectual property is owned by Mr. Vistakula.
Competing technologies that provide partial solutions include: phase change materials (PCM), vapor
compression, chemical reaction, and electric variable resistive heating. Yet no current solution is able to
provide the combination of multipurpose warmth and coolness capabilities, sustained temperatures,
extended performance, failure tolerance, and mobility that ClimaGear can.

10. TECHNOLOGY 194: Power over Ethernet
Technology Commercialization Project: Power over Ethernet
This is one of a series of projects completed by Panidea consultants while employed with the IC2 Institute at
The University of Texas at Austin. The program structure was generally six months of technology evaluation,
where the list of options was reduced from several hundred to a viable 12 – 15 technologies selected for
business development. In the second six months, we were responsible for taking the innovation to the
marketplace, identifying key partners, establishing relationships with these organizations and the key staff,
and getting engagement agreements signed by both the company and the innovator to advance the
technology in the marketplace. Given the program structure, these contacts were identified, relationships
established, and agreement signed within the program timeframes.
The key aspect to the process was in the ongoing development of relationships to bring the product to the
marketplace. These contacts validated the technology as well and became customers as part of the process.
Power over Ethernet (PoE) is a system to transmit electrical power and data to remote devices over standard
twisted-pair cable in an Ethernet network. This technology is useful for powering IP telephones, low powered
wireless LAN access points, network cameras, remote network switches, embedded computers, and other
appliances where it would be inconvenient, expensive, or infeasible to supply power separately.
The Powered Ethernet Splitter (PES) or Powered Ethernet Module (PEM) provide the first commercially
available devices to provide PoE output loads of up to 33 Watts while maintaining compliance with the IEEE
802.3af standard. By expanding available power, the PES and PEM devices significantly expand the types and
number of appliances that can be powered over the network. The PES was designed to “PoE enable” legacy
network appliances while the PEMs were built to integrate directly into the product designs of network
appliance devices.
The developers see the technology as offering the advantage of the power limits of the new 802.3at standard
with the inter-operability of the 802.3af standard.

11. Technology K2118: Dual Blade Counter Rotating Wind Turbine
Technology Commercialization Project: Dual Blade Counter Rotating Wind Turbine
This is one of a series of projects completed by Panidea consultants while employed with the IC2 Institute at
The University of Texas at Austin. The program structure was generally six months of technology evaluation,
where the list of options was reduced from several hundred to a viable 12 – 15 technologies selected for
business development. In the second six months, we were responsible for taking the innovation to the
marketplace, identifying key partners, establishing relationships with these organizations and the key staff,
and getting engagement agreements signed by both the company and the innovator to advance the
technology in the marketplace. Given the program structure, these contacts were identified, relationships
established, and agreement signed within the program timeframes.
The key aspect to the process was in the ongoing development of relationships to bring the product to the
marketplace. These contacts validated the technology as well and became customers as part of the process.
The Dual Rotor Counter Rotating Wind Power Generator is a wind generator that utilizes one set of blades to
spin the rotor clockwise and another set of blades that spin a rotating stator counterclockwise. Each blade set
has 3 blades. Front blades revolve clockwise and rear blades revolve counterclockwise. High efficiencies in
low speed winds are attained through a dual rotor counter rotating wind turbine system that connects the
rotor and stator to the blades. The result is a yield rpm of almost double that of current wind turbines for a
given wind speed. The technology was invented for the small to medium sized wind markets.
The chief problem the technology solves is improved turbine performance in low-wind conditions: 4.5 mph
for a 1kw wind turbine, as compared to the 6.7 mph required for the single rotor competitor model. The
technology is said to generate two times (200%) the power produced by the existing generator in the same
wind velocity. Additionally, the wind turbine creates less noise by using centripetal force instead of
centrifugal force used by the noisier current solutions.
AHHA Energy’s patented design utilizes one set of blades to spin the rotor clockwise and another set of blades
that spin a rotating stator counterclockwise. Nine months of field trials showed a yield of 18kw-20kw (8 m/s)
for the dual rotor wind turbine while the Bergey product showed a yield of 8.5kw-10kw (12 m/s). The
technology was invented for the small to medium sized wind markets. The technology was developed to be a
stand-alone product that replaces the need for a single rotor wind generator.

12. EX EC UT IV E S U M MA RY
Technology Commercialization Project: Fruit Coating
This is one of a series of projects completed by Panidea consultants while employed with the IC2 Institute at
The University of Texas at Austin. The program structure was generally six months of technology evaluation,
where the list of options was reduced from several hundred to a viable 12 – 15 technologies selected for
business development. In the second six months, we were responsible for taking the innovation to the
marketplace, identifying key partners, establishing relationships with these organizations and the key staff,
and getting engagement agreements signed by both the company and the innovator to advance the
technology in the marketplace. Given the program structure, these contacts were identified, relationships
established, and agreement signed within the program timeframes.
The key aspect to the process was in the ongoing development of relationships to bring the product to the
marketplace. These contacts validated the technology as well and became customers as part of the process.
The technology which is the subject of this report, fruit coatings, is a water soluble coating that can extend the
shelf life of fruits and vegetables by up to two weeks without refrigeration. The coated produce retains all of
its natural characteristics and natural water loss is significantly reduced. The coating can be applied
manually, allowing the process to be done in rural areas with limited or no electrical power. One liter of
coating will cover approximately 100 kilograms of fruit.
Although India is the world’s second largest producer of fruits and vegetables, approximately 25% of that
produce spoils and never reaches the consumer resulting in billions of dollars of losses in vegetables alone.
The losses are due to the fact that most fruits are harvested slowly by hand and limited refrigeration facilities
are available for post harvest treatment. By extending the produce’s shelf life, this low cost coating would
allow farmers to expand their market reach significantly. Primarily, it would help give farmers more time to
transport their produce to more distant markets. In addition, by allowing the produce to be stored for a
longer time, the coating would help farmers avoid price fluctuations due to gluts in the market and increase
their overall profits.

13. Technology K2110 – iTPA Diagnostic Method
Technology Commercialization Project: iTPA Diagnostic Method
This is one of a series of projects completed by Panidea consultants while employed with the IC2 Institute at
The University of Texas at Austin. The program structure was generally six months of technology evaluation,
where the list of options was reduced from several hundred to a viable 12 – 15 technologies selected for
business development. In the second six months, we were responsible for taking the innovation to the
marketplace, identifying key partners, establishing relationships with these organizations and the key staff,
and getting engagement agreements signed by both the company and the innovator to advance the
technology in the marketplace. Given the program structure, these contacts were identified, relationships
established, and agreement signed within the program timeframes.
The key aspect to the process was in the ongoing development of relationships to bring the product to the
marketplace. These contacts validated the technology as well and became customers as part of the process.
RapleGene has developed a product called RapiDx®, a diagnostic method designed to test for a number of
pathogens, including Mycobacterium tuberculosis, Chlamydia trachomatis, Neisseria gonorrhoeas, E. coli
O157:H7, Salmonella spp., Hepatitis B virus, Novel influenza A (H1N1) and Influenza. The Hepatitis C virus kit
will be available in the first quarter of this year. The company is currently developing additional testing
capabilities for RapiDx®, with test kits for at least five new pathogens expected to be available before the end
of 2010. RapiDx® employs a technology called iTPA™ (isothermal target and probe amplification), a novel
isothermal amplification method in which the target nucleic acids and signal probes are amplified
simultaneously in a single tube. The amplified signal probes are detected through the florescent resonance
energy transfer (FRET) method which does not require any post-amplification process. Additional products
are planned for the future, including a point of care solution.

14. Technology K2127: CDMA Wireless Microphone with Portable Speaker
Technology Commercialization Project: CDMA Wireless Microphone with Portable Speaker
This is one of a series of projects completed by Panidea consultants while employed with the IC2 Institute at
The University of Texas at Austin. The program structure was generally six months of technology evaluation,
where the list of options was reduced from several hundred to a viable 12 – 15 technologies selected for
business development. In the second six months, we were responsible for taking the innovation to the
marketplace, identifying key partners, establishing relationships with these organizations and the key staff,
and getting engagement agreements signed by both the company and the innovator to advance the
technology in the marketplace. Given the program structure, these contacts were identified, relationships
established, and agreement signed within the program timeframes.
The key aspect to the process was in the ongoing development of relationships to bring the product to the
marketplace. These contacts validated the technology as well and became customers as part of the process.
“The AepelPhone” is the world’s first CDMA Wireless Microphone. The CDMA feature provides excellent
sound quality with no background noise and has little influence of signal mixing or chopping, as can occur
with microphones using Bluetooth. The CDMA Development Group says, “CDMA consistently provides better
capacity for voice and data communications than other commercial mobile technologies”
A small wireless headset is worn that transmits a radio signal to a 3”X4”X1” speaker that is worn on the
speaking individual’s hip, projecting a crisp sound quality to small and medium sized audiences. Its small size
and ultra light weight make the AepelPhone mobile, allowing the speaking individual to continue amplifying
their voice while moving around- inside or outside. Ms. Stephanie Niemeyer, Director of Docent Tours at the
Jack S. Blanton Museum of Art, has expressed an interest in using the AepelPhone to give tours at the
Museum. Niemeyer was particularly impressed by the AepelPhone’s sound quality, light weight, and comfort.
The AepelPhone’s speaker/amplifier can additionally be used in AUX mode to amplify music library or DVD
from computer with an “audio-out” cord to provide excellent sound.

15. Technology 236: Acoustic Life Detector
Technology Commercialization Project: Acoustic Life Detector
This is one of a series of projects completed by Panidea consultants while employed with the IC2 Institute at
The University of Texas at Austin. The program structure was generally six months of technology evaluation,
where the list of options was reduced from several hundred to a viable 12 – 15 technologies selected for
business development. In the second six months, we were responsible for taking the innovation to the
marketplace, identifying key partners, establishing relationships with these organizations and the key staff,
and getting engagement agreements signed by both the company and the innovator to advance the
technology in the marketplace. Given the program structure, these contacts were identified, relationships
established, and agreement signed within the program timeframes.
The key aspect to the process was in the ongoing development of relationships to bring the product to the
marketplace. These contacts validated the technology as well and became customers as part of the process.
The technology is used to detect and save human beings trapped under the debris of collapsed buildings due
to earth quake or land slide. This equipment is based on highly air sensitive acoustic sensor and audio signal
processing to clearly listen to the victim’s low frequency sound from below the debris. The sensors and
related equipment are hermetically sealed and hence it can be used in wet or raining environment after a
calamity.
The Acoustic life detector has three sub systems, namely probe assembly, electronics control unit and a head
phone set. The probe assembly consists of a low frequency acoustic sensor that is highly sensitive, to pickup
even very low human voices or any other sound made by the persons trapped under the debris. The sensor
uses a highly sensitive piezoelectric material for converting the sound signal to electrical voltages. The probe
head is rigidly coupled with a rigid Aluminum telescopic tube, which can be extended up to 2 m, which will
help to the probe head through the gap of debris, if required. The electronics unit is designed using ICs. An
amplifier in the assembly gives sufficient output to hear through head phones. It consists of a volume control
switch and tone selector switch, sensor and headphone sockets. The electronics module is powered by four
1.5V AA type battery cells. It is very small and compact and is provided with a nylon waist belt for the
operator to wrap around his waist. The headphone is is a standard stereo type headphone with extended
microphone facility for two way communication between the operator and victim

16. Technology 067: High Altitude Pulmonary Oedema (HAPO) Chamber
Technology Commercialization Project: High Altitude Pulmonary Oedema (HAPO) Chamber
This is one of a series of projects completed by Panidea consultants while employed with the IC2 Institute at
The University of Texas at Austin. The program structure was generally six months of technology evaluation,
where the list of options was reduced from several hundred to a viable 12 – 15 technologies selected for
business development. In the second six months, we were responsible for taking the innovation to the
marketplace, identifying key partners, establishing relationships with these organizations and the key staff,
and getting engagement agreements signed by both the company and the innovator to advance the
technology in the marketplace. Given the program structure, these contacts were identified, relationships
established, and agreement signed within the program timeframes.
The key aspect to the process was in the ongoing development of relationships to bring the product to the
marketplace. These contacts validated the technology as well and became customers as part of the process.
The HAPO Chamber is a life saving equipment for soldiers positioned at high altitudes. HAPO is a condition in
which fluid accumulates in lungs causing severe illness. Rapid descent, a treatment of choice, is often
impossible due to the topography, adverse weather, or non-availability of transport. In such a scenario,
portable hyperbaric bag/chambers present an inexhaustible light weight source of additional oxygen
pressure which leads to rapid relief of symptoms of high altitude illness. In the Indian context, the incidence
of HAPO was noted to be as high as 15.5% in a group of fresh inductees who were rapidly transported to
altitudes between 3,355 and 5,490 m (11,000–18,000 ft)2, 3
Years of R&D effort coupled with the evaluation has culminated in the development of an automated bag. The
operating pressure inside the developed bag is 2.5psi vis-à-vis 2psi of the above mentioned internationally
available bags, thereby enhancing the virtual descent of the patient and hence the recovery. The developed
bag is 2.1m long, 0.65m diameter at the head end and 0.5m diameter at the foot end, with a volume of
approximately 600 liters to accommodate the HAPO patient, even with the multiple layers of cold-clothing.
The bag is provided with a pre-set leak control valve to bleed continuously at a rate of 20 liters per minute in
order to avoid the build-up of carbon dioxide inside the bag and a safety pressure relief valve in order to
prevent the excessive pressure inside the bag. Several user friendly features have been incorporated in the
developed bag. All the materials have been selected to withstand sub-zero temperatures encountered in the
usage.

17. Technology 104: MentorPort
Technology Commercialization Project: MentorPort
This is one of a series of projects completed by Panidea consultants while employed with the IC2 Institute at
The University of Texas at Austin. The program structure was generally six months of technology evaluation,
where the list of options was reduced from several hundred to a viable 12 – 15 technologies selected for
business development. In the second six months, we were responsible for taking the innovation to the
marketplace, identifying key partners, establishing relationships with these organizations and the key staff,
and getting engagement agreements signed by both the company and the innovator to advance the
technology in the marketplace. Given the program structure, these contacts were identified, relationships
established, and agreement signed within the program timeframes.
The key aspect to the process was in the ongoing development of relationships to bring the product to the
marketplace. These contacts validated the technology as well and became customers as part of the process.
MentorPort is a social network where people offer to providing training and coaching. MentorPort provide a
platform for promoting and registering for Specialized Knowledge Modules (SKMs), which are training events
run by mentors and attended by mentees. There are three revenue streams: 1) Fees for conducting Special
Knowledge Modules (SKMs); 2) Advertising throughout the platform; 3) Sponsors for specific events.
With MentorPort, prospective mentors make themselves available to mentees. The innovators of MentorPort,
in their research, have seen mentors want to control when and how they interact with mentees, are
motivated by the perception that they successful and respected enough to be considered ‘mentors,’ and are
interested in a platform to give back and help others succeed.
There are three revenue streams:
 Conducting Special Knowledge Modules (SKMs)
 Advertising throughout the platform
 Sponsors for specific events.

18. Technology 81: Chukungunya Antigen ELISA
Technology Commercialization Project: Chukungunya Antigen ELISA
This is one of a series of projects completed by Panidea consultants while employed with the IC2 Institute at
The University of Texas at Austin. The program structure was generally six months of technology evaluation,
where the list of options was reduced from several hundred to a viable 12 – 15 technologies selected for
business development. In the second six months, we were responsible for taking the innovation to the
marketplace, identifying key partners, establishing relationships with these organizations and the key staff,
and getting engagement agreements signed by both the company and the innovator to advance the
technology in the marketplace. Given the program structure, these contacts were identified, relationships
established, and agreement signed within the program timeframes.
The key aspect to the process was in the ongoing development of relationships to bring the product to the
marketplace. These contacts validated the technology as well and became customers as part of the process.
The present innovation is a kit for early detection of Chikungunya (CHIKV) with high degree of sensitivity and
specificity is based on the principle of double antibody sandwich ELISA. CHIKV is an insect-borne virus, of the
genus, Alphavirus, that is transmitted to humans by virus-carrying Aedes mosquitoes in a human subject of
Chikungunya infection. The kit will be useful for early clinical diagnosis of Chikungunya virus. Purified rabbit
anti-Chikungunya virus polyclonal antibody was coated on the ELISA wells to capture CHIKV antigen in
patient sera. After binding, the rabbit anti-CHIKV antibody was used in a sandwich format. The resulting
complex is detected using enzyme substrate reaction. Appearance of color change to brown indicates positive
result.
This kit is validated with more than 200 clinical samples (Serum and CSF), collected from recent Chikungunya
outbreaks in different part of India (2006-2008). It revealed >85% correlation with genetic assays and virus
isolation. This kit is also validated for detection of Chikungunya virus antigen in infected culture supernatant.
This kit is also evaluated at the Central India Institute of Medical Science (CIIMS), Nagpur, India.
Chikungunya has recently emerged as one of the most important arboviral infection of public health
significance. Explosive outbreaks were reported in many areas of India and Indian Ocean islands since 2005.
Large numbers of imported cases were also reported among travelers in temperate countries. There is no
effective therapy or prophylaxis available against this disease. Therefore early diagnosis plays an important
role in proper control and effective management of patients.
A CHIKV infection is quite painful and death may result. The current method of detection is after the few first
cases are confirmed, most clinics diagnose from symptoms in the field. The kit will be useful for early clinical
diagnosis of Chikungunya virus through detection of viral antigen even on day 2 of fever

19. Technology 78: Dengue IgM ELISA
Technology Commercialization Project: Dengue IgM ELISA
This is one of a series of projects completed by Panidea consultants while employed with the IC2 Institute at
The University of Texas at Austin. The program structure was generally six months of technology evaluation,
where the list of options was reduced from several hundred to a viable 12 – 15 technologies selected for
business development. In the second six months, we were responsible for taking the innovation to the
marketplace, identifying key partners, establishing relationships with these organizations and the key staff,
and getting engagement agreements signed by both the company and the innovator to advance the
technology in the marketplace. Given the program structure, these contacts were identified, relationships
established, and agreement signed within the program timeframes.
The key aspect to the process was in the ongoing development of relationships to bring the product to the
marketplace. These contacts validated the technology as well and became customers as part of the process.
Dengue, the most common arboviral illness transmitted worldwide, is caused by infection with 1 of the 4
serotypes of dengue virus. Dengue is transmitted by mosquitoes of the genus Aedes, which are widely
distributed in subtropical and tropical areas of the world, and is classified as a major global health threat by
the World Health Organization (WHO).
The innovation is a type of medical equipment and reagents in the form of kit for early detection of dengue
fever. The subject technology is based on indirect ELISA principle, using recombinant dengue protein
antigen. The wells of ELISA plate is coated with recombinant dengue antigens. The Dengue specific antibodies
present in the test sera bind with antigen. The reaction is further processed with the addition of antihuman
IgM-HRP conjugate. The reaction is observed through colorimetric interaction with chromogen. Color
development is indicative of the presence of Dengue virus specific IgM antibodies in the test sample.
The technology claims that the cross reactivity with other co-circulating members of flavivirus grous are
ruled out by employing recombinant antigen; thereby making the kit more specific for dengue virus only.

20. Technology Commercialization Project: Heat Stabilized Narrow Fabrics
This is one of a series of projects completed by Panidea consultants while employed with the IC2 Institute at
The University of Texas at Austin. The program structure was generally six months of technology evaluation,
where the list of options was reduced from several hundred to a viable 12 – 15 technologies selected for
business development. In the second six months, we were responsible for taking the innovation to the
marketplace, identifying key partners, establishing relationships with these organizations and the key staff,
and getting engagement agreements signed by both the company and the innovator to advance the
technology in the marketplace. Given the program structure, these contacts were identified, relationships
established, and agreement signed within the program timeframes.
The key aspect to the process was in the ongoing development of relationships to bring the product to the
marketplace. These contacts validated the technology as well and became customers as part of the process.
The technology, Heat Stabilized Narrow Fabrics, is a heat setting process that leads to improvement in the
elastic recovery property of textile assemblies, viz., nylon and polyester tapes and cordages. The improved
elastic recovery (or less permanent set) leads to improved life of materials during usage that involves
cyclic/repeated load applications. This technology was developed to minimize the problem of permanent set
observed in parachute rigging line materials when subjected to repeated usage. The technology involves a
heat setting machine that has been utilized on an industrial scale providing improved elastic recovery
property for the subject material allowing increased usage and longevity of cordage. The primary benefit of
this technology is focused on improving the elastic recovery properties of cordage and rope. The technology
could be applied to nearly any nylon or poly fiber and increase its longevity and elastic recovery with no
change in material property beyond a slight yellowing.

21. : Detection of IgM antibodies for serodiagnosis of Japanese encepahalitis infection
Technology Commercialization Project: Detection of IgM antibodies for serodiagnosis of Japanese
encepahalitis infection
This is one of a series of projects completed by Panidea consultants while employed with the IC2 Institute at
The University of Texas at Austin. The program structure was generally six months of technology evaluation,
where the list of options was reduced from several hundred to a viable 12 – 15 technologies selected for
business development. In the second six months, we were responsible for taking the innovation to the
marketplace, identifying key partners, establishing relationships with these organizations and the key staff,
and getting engagement agreements signed by both the company and the innovator to advance the
technology in the marketplace. Given the program structure, these contacts were identified, relationships
established, and agreement signed within the program timeframes.
The key aspect to the process was in the ongoing development of relationships to bring the product to the
marketplace. These contacts validated the technology as well and became customers as part of the process.
Japanese encephalitis (JE) is the most important viral encephalitis of public health significance. It is endemic
through out south east Asia, including India. This virus is a member of the genus Flavivirus, family
Flaviviridae, and is transmitted between vertebrate hosts by mosquitoes, principally by Culex
tritaeniorhynchus. Approximately 45,000 JE cases with 10,000 deaths were notified. Annually JE outbreaks
are reported at regular interval from many parts of India. There is no effective therapy available against this
disease. Therefore early diagnosis plays an important role in proper control and effective management of
patients.
This kit is based on indirect ELISA principle, using recombinant protein antigen. The wells of ELISA plate was
coated with recombinant JEV antigens. The JEV specific antibodies present in the test sera bind with antigen.
The reaction was further processed with the addition of antihuman IgM-HRP conjugate. The reaction was
observed through colorimetric interaction with chromogen. Color development is indicative of the presence
of JE virus specific IgM antibodies in the test sample.
The cross reactivity with other co-circulating members of flavivirus grous were ruled out by employing
recombinant antigen thereby making the kit more specific for JE virus only.

22. Technology Commercialization Project: Ceramic Composites Integral Armour
Technology Commercialization Project: Ceramic Composites Integral Armour
This is one of a series of projects completed by Panidea consultants while employed with the IC2 Institute at
The University of Texas at Austin. The program structure was generally six months of technology evaluation,
where the list of options was reduced from several hundred to a viable 12 – 15 technologies selected for
business development. In the second six months, we were responsible for taking the innovation to the
marketplace, identifying key partners, establishing relationships with these organizations and the key staff,
and getting engagement agreements signed by both the company and the innovator to advance the
technology in the marketplace. Given the program structure, these contacts were identified, relationships
established, and agreement signed within the program timeframes.
The key aspect to the process was in the ongoing development of relationships to bring the product to the
marketplace. These contacts validated the technology as well and became customers as part of the process.
The present innovation is a unique technology to produce lightweight, maintenance-free and easily repairable
multifunctional engineered material known as Ceramic Composite Integral Armour which can be used for
structural requirements and ballistic threats. The innovation is lighter and more efficient than metals and it
can be integrated with the composites to provide alternative solutions to the current bulky metallic
structures with add-on/strap-on armour.
The armour combines the structure with ballistic protection and is fabricated by Vacuum Assisted Resisted
Resin Transfer Moulding (VARTM) process. Ceramic-composite integral armour has ceramic layer, rubber
layer, backing composites structural layer, cover layer and other functional layers such as layers for fire-
protection. The ceramic layer provides primary ballistic protection while the composites layer is the
structural layer.
Integral armour is lighter as it exploits the benefits of ceramics more than strap-on armour because of the
additional confinement of ceramics achieved due to integration of structure and armour. Its modular
construction using small ceramic tiles allows for its easy repair after impact and easy compliance with
complex shapes. There is no need of spall-liner leading to additional weight reduction.

23. Technology 028: Electrochromatic Window
Technology Commercialization Project: Electrochromatic Window
This is one of a series of projects completed by Panidea consultants while employed with the IC2 Institute at
The University of Texas at Austin. The program structure was generally six months of technology evaluation,
where the list of options was reduced from several hundred to a viable 12 – 15 technologies selected for
business development. In the second six months, we were responsible for taking the innovation to the
marketplace, identifying key partners, establishing relationships with these organizations and the key staff,
and getting engagement agreements signed by both the company and the innovator to advance the
technology in the marketplace. Given the program structure, these contacts were identified, relationships
established, and agreement signed within the program timeframes.
The key aspect to the process was in the ongoing development of relationships to bring the product to the
marketplace. These contacts validated the technology as well and became customers as part of the process.
Defence Laboratory, Jodhpur has designed and developed Electrochromic Windows of size 14” X 18”. Smart
window technology is based on such materials whose optical properties change in response to a small
electrical current. The developed windows have ability to dynamically control solar transmission i.e. between
17-70% with fast switching time and low DC power consumption from 1 to 3V. Control is possible through a
dimmer switch or remote control device.
Such windows provide 30-40% energy saving in terms of cooling, lightning and peak utility electric loads. It
transmits high levels of visible light while reflecting invisible solar heat and therefore provides both visual
and thermal comfort

24. Technology 86: Herbal Adjuvant :DIP-HIP
Technology Commercialization Project: Herbal Adjuvant: DIP-HIP
This is one of a series of projects completed by Panidea consultants while employed with the IC2 Institute at
The University of Texas at Austin. The program structure was generally six months of technology evaluation,
where the list of options was reduced from several hundred to a viable 12 – 15 technologies selected for
business development. In the second six months, we were responsible for taking the innovation to the
marketplace, identifying key partners, establishing relationships with these organizations and the key staff,
and getting engagement agreements signed by both the company and the innovator to advance the
technology in the marketplace. Given the program structure, these contacts were identified, relationships
established, and agreement signed within the program timeframes.
The key aspect to the process was in the ongoing development of relationships to bring the product to the
marketplace. These contacts validated the technology as well and became customers as part of the process.
DIPAS has developed a new herbal adjuvant, called DIP-HIP, and compared its efficacy with complete
Freund’s Adjuvant and Alum. Animals were immunized with different antigens. The results indicated that
antigen specific immunoglobulin levels were significantly enhanced by DIP-HIP. The cytokine profile also
correlated very well with the Th1 and Th2 type of immune response generated on administration of DIP-HIP.
Interestingly, using different strains and different species, DIP-HIP responded better than CFA. The
sustenance of antibody response in the body was for about more than four months using DIP-HIP.
The technology is a herbal adjuvant which is an agent that may stimulate the immune system and increase the
response to a vaccine, without having any specific antigenic effect in itself. It causes no injection site reaction,
pyrogenecity or muscular damage. The technology elicits immune response against bacterial, viral and
recombinant proteins, enhances immunogenecity of weak antigens by generating both humoral as well as cell
mediated immune response.

25. Technology 024: Aluminum Pallet
Technology Commercialization Project: Aluminum Pallet
This is one of a series of projects completed by Panidea consultants while employed with the IC2 Institute at
The University of Texas at Austin. The program structure was generally six months of technology evaluation,
where the list of options was reduced from several hundred to a viable 12 – 15 technologies selected for
business development. In the second six months, we were responsible for taking the innovation to the
marketplace, identifying key partners, establishing relationships with these organizations and the key staff,
and getting engagement agreements signed by both the company and the innovator to advance the
technology in the marketplace. Given the program structure, these contacts were identified, relationships
established, and agreement signed within the program timeframes.
The key aspect to the process was in the ongoing development of relationships to bring the product to the
marketplace. These contacts validated the technology as well and became customers as part of the process.
This technology is an improved aluminum pallet. With a low weight, but a capacity comparable to similar
wood pallets and a price point significantly lower than existing aluminum pallets, this technology was
designed to compete directly with wood pallets, the overwhelming market leader. The product is designed
pallets for both the one-way air logistics market and for use in “closed-loop” systems, where the pallets are
used repeatedly over their useful life. The pallet design is patented based upon its unique structurally
qualities combining a “prominence and depression” form design of the deck boards and an “inner cap system”
for the posts. Both of these elements contribute to the pallets’ light weight and high strength. The light
weight of the pallet helps to reduce shipping costs, particularly in air logistics applications, and the pallet
strength and durability contributes to a longer useful life as compared to standard wood products.
The aluminum pallet is designed to compete directly against the wooden pallet, a trusted and proven
technology that accounts for 93% of the global pallet market. As compared to wood, the aluminum pallet
offers the following advantages; it is fireproof, does not require heat treatment or fumigation to comply with
international shipping standards, lighter weight, cleaner and safer to handle.

26. Technology 027: Liquid Leak Detector Sensor Film and Controller
Technology Commercialization Project: Liquid Leak Detector Sensor Film and Controller
This is one of a series of projects completed by Panidea consultants while employed with the IC2 Institute at
The University of Texas at Austin. The program structure was generally six months of technology evaluation,
where the list of options was reduced from several hundred to a viable 12 – 15 technologies selected for
business development. In the second six months, we were responsible for taking the innovation to the
marketplace, identifying key partners, establishing relationships with these organizations and the key staff,
and getting engagement agreements signed by both the company and the innovator to advance the
technology in the marketplace. Given the program structure, these contacts were identified, relationships
established, and agreement signed within the program timeframes.
The key aspect to the process was in the ongoing development of relationships to bring the product to the
marketplace. These contacts validated the technology as well and became customers as part of the process.
The Liquid Leak Detection Sensor Film technology is an innovative and cost efficient liquid leak detection
sensor film that can quickly and effectively identify liquid leaks in the semiconductor industry. The
technology uses a conductive silver nano ink on a polymer film with a flat band structure to be used easily on
the ground or around pipes and tools as needed. The system communicates via radio frequency and after a
detection event; the film can be wiped and reused unlike other cable detection systems.
The film is more sensitive to liquids than existing technologies and can detect a liquid leak with one ml of
liquid and the response time is 1-5 seconds. Also, the technology can actually identify the location of the leak
in the facility, again reducing response time to the leak. As a result, the film can limit the costs associated
with hazardous or expensive chemical leaks and associated clean-up efforts.
The subject technology can withstand accidental contact or compression that can trigger expensive false
alarms, and the initial cost to install the film is the cheapest in the industry according to the inventor.
The liquid leak sensor is a film capable of tampering and pressure acceptance without alarm signaling.

27. Komodo Technologies allows obtaining information in field, in remote locations and in difficult access sending
the information to databases in real time for its process. Creates operating and maintenance reports of all
kind of assets.
Breve descripción del Estatus de Desarrollo de la tecnología y el Tiempo estimado para su comercialización.
Por favor incluya información sobre productos o servicios disponibles para esta tecnología. Brevemente
describa el Potencial de Mercado de la tecnología, así como las ventajas de la misma sobre otras tecnologías
competidoras.
The competition industry for KOMODO is defined as “Mobile Middleware Developer”. According to the IDC,
the “MM” market rose to USD$424.4 millons in 2003 with a rate of 27.4%. Estimates for 2008 contemplate
that the market will rise to $1,300 million representing an increase of 24.2%. KOMODO solutions will have
among its operative advantages the capacity for registration through bar code and RFID.
Venture Development Corporation estimates that the RFID industry will have an annual compound growth of
22.6% in 5 years with a market increase of USD$2.7 billion by 2007.
Technology Commercialization Project: Komodo Technologies
This is one of a series of projects completed by Panidea consultants while employed with the IC2 Institute at
The University of Texas at Austin. The program structure was generally six months of technology evaluation,
where the list of options was reduced from several hundred to a viable 12 – 15 technologies selected for
business development. In the second six months, we were responsible for taking the innovation to the
marketplace, identifying key partners, establishing relationships with these organizations and the key staff,
and getting engagement agreements signed by both the company and the innovator to advance the
technology in the marketplace. Given the program structure, these contacts were identified, relationships
established, and agreement signed within the program timeframes.
The key aspect to the process was in the ongoing development of relationships to bring the product to the
marketplace. These contacts validated the technology as well and became customers as part of the process.
Komodo Technologies has a suite called KomoSync comprised of three modules. Module 1, OperRoutes, is
already available, SUEZ, largest energy company worldwide, is currently using it. The other two modules,
ACT ivo and EMISmobile are in their development stage. ACTivo will be available for its commercialization in
February 2007 and EMISmobile by June 2007.

28. Breve nombre de la tecnología:
Physical and Informatics Security System for Mobil Devices
En lenguaje NO científico o técnico por favor describa “que hace” la tecnología (NO como funciona). 100
palabras o menos.
Technology Commercialization Project: Portable Device Security System
This is one of a series of projects completed by Panidea consultants while employed with the IC2 Institute at
The University of Texas at Austin. The program structure was generally six months of technology evaluation,
where the list of options was reduced from several hundred to a viable 12 – 15 technologies selected for
business development. In the second six months, we were responsible for taking the innovation to the
marketplace, identifying key partners, establishing relationships with these organizations and the key staff,
and getting engagement agreements signed by both the company and the innovator to advance the
technology in the marketplace. Given the program structure, these contacts were identified, relationships
established, and agreement signed within the program timeframes.
The key aspect to the process was in the ongoing development of relationships to bring the product to the
marketplace. These contacts validated the technology as well and became customers as part of the process.
This technology is breaking a paradigm on physical and informatics security for mobile devices (laptops,
iPods, briefcases, purses, etc.) focused on an antitheft process. Such technology will create a secure
environment for mobile devices and all confidential digital information that may be included.
We can clearly illustrate our technology in the first prototype applied to laptops’ security.
Is an antitheft security electronic alarm for laptops which also protects information in three different ways,
before robbery (neglect robbery), during robbery (physical attack on robbery) and after robbery (self
destruction of the information). The information is continuously backed up through our automatic back up
system in real time (when a file is created or modified it is backed up at that time).
This technology may be licensed to trademarks for laptop, briefcase and any similar device requiring superior
security.

29. Technology 77: Typhigen Kit
Technology Commercialization Project: Typhigen Kit
This is one of a series of projects completed by Panidea consultants while employed with the IC2 Institute at
The University of Texas at Austin. The program structure was generally six months of technology evaluation,
where the list of options was reduced from several hundred to a viable 12 – 15 technologies selected for
business development. In the second six months, we were responsible for taking the innovation to the
marketplace, identifying key partners, establishing relationships with these organizations and the key staff,
and getting engagement agreements signed by both the company and the innovator to advance the
technology in the marketplace. Given the program structure, these contacts were identified, relationships
established, and agreement signed within the program timeframes.
The key aspect to the process was in the ongoing development of relationships to bring the product to the
marketplace. These contacts validated the technology as well and became customers as part of the process.
The Defense Research Development Organization of India has developed a simple agglutination based antigen
detection test where observation can be taken by naked eyes. The innovation rapid diagnostic `typhigen' kit
using recombinant DNA technology enables direct detection of the salmonella typhi antigen in the patient's
serum within one to three minutes, thus allowing early treatment of the affected persons. It is an
agglutination based technology for direct detection of typhoid antigen in clinical samples. It was developed
using immunological and biotechnological techniques. It is highly sensitive and specific system and rapid in
nature. Serodiagnosis of typhoid using the Widal test is not specific and sensitive; therefore, an alternate
method of antigen detection was attempted and the kit was developed
The test can be performed on plasma or serum of suspected typhoid patient. It can be performed in the
laboratory and in the field as well. To conduct the test, no special training is required. The reagent can be
stored in cold four degree Celsius for more than nine months. To develop the system, we have amalgated
recombinant DNA technology with immunological techniques.

30. Technology Commercialization Project: Explosive Detection Kit
This is one of a series of projects completed by Panidea consultants while employed with the IC2 Institute at
The University of Texas at Austin. The program structure was generally six months of technology evaluation,
where the list of options was reduced from several hundred to a viable 12 – 15 technologies selected for
business development. In the second six months, we were responsible for taking the innovation to the
marketplace, identifying key partners, establishing relationships with these organizations and the key staff,
and getting engagement agreements signed by both the company and the innovator to advance the
technology in the marketplace. Given the program structure, these contacts were identified, relationships
established, and agreement signed within the program timeframes.
The key aspect to the process was in the ongoing development of relationships to bring the product to the
marketplace. These contacts validated the technology as well and became customers as part of the process.
The technology which is the subject of this report, Explosives Detection Kit is a compact unit for conducting
preliminary tests on the spot for identification and detection of explosives on hands and surfaces suspected of
contamination while preparing or carrying explosives. It is designed and developed on the basis of compound
specific color producing spot test. Four reagents are used for detection of the specific explosive ingredient.
The kit has been developed for identification of explosives in pre and post explosion field conditions.
The driving benefit of this technology is cost savings. The innovator believes this kit can be commercialized at
a cost point which would be reasonable to global markets. Through interviews it seems apparent that
emerging countries would likely be stronger market opportunities for this kit. Cost points will be a major
consideration for those potential markets.
The kit is completely developed and being utilized by various security forces in India. The feedback from
these security forces has been very encouraging.
The kit has been patented in India. Ownership is with the DRDO. The patent was granted on March 8, 1996.
Other similar patents around the world exist. In the United States at least five similar patents were
uncovered, so additional research by qualified IP professionals will be needed.

31. Technology Commercialization Project: High Velocity Microscope
This is one of a series of projects completed by Panidea consultants while employed with the IC2 Institute at
The University of Texas at Austin. The program structure was generally six months of technology evaluation,
where the list of options was reduced from several hundred to a viable 12 – 15 technologies selected for
business development. In the second six months, we were responsible for taking the innovation to the
marketplace, identifying key partners, establishing relationships with these organizations and the key staff,
and getting engagement agreements signed by both the company and the innovator to advance the
technology in the marketplace. Given the program structure, these contacts were identified, relationships
established, and agreement signed within the program timeframes.
The key aspect to the process was in the ongoing development of relationships to bring the product to the
marketplace. These contacts validated the technology as well and became customers as part of the process.
We intend to produce revolutionary new non-linear laser microscopes ready to be placed on the market that
is four times faster and more efficient than the presently available ones and that makes possible the
measurement of the brains electric/physiological activity, photochemical stimulation with kHz-mHz velocity,
and directed separation of neurons or their complements with laser.
With the help of our equipment scientist can study the work of neuron networks in animal tests or in human
brain cuts, the synopsis going on in the neurons, and we can elaborate new pharmacological tests.

32. Technology Commercialization Project: Contactless Restore of Records
This is one of a series of projects completed by Panidea consultants while employed with the IC2 Institute at
The University of Texas at Austin. The program structure was generally six months of technology evaluation,
where the list of options was reduced from several hundred to a viable 12 – 15 technologies selected for
business development. In the second six months, we were responsible for taking the innovation to the
marketplace, identifying key partners, establishing relationships with these organizations and the key staff,
and getting engagement agreements signed by both the company and the innovator to advance the
technology in the marketplace. Given the program structure, these contacts were identified, relationships
established, and agreement signed within the program timeframes.
The key aspect to the process was in the ongoing development of relationships to bring the product to the
marketplace. These contacts validated the technology as well and became customers as part of the process.
There is an invaluable cultural treasure of several thousand of wax cylinders stored in the Museum of
Ethnography and Institute for Musicology in Hungary. They contain the early collections of folk music by Bela
Vikar, Bela Bartok, Zoltan Kodaly and other researchers, in a unique and unrepeatable form. The process of
replaying the cylinders is destructive. The signal/noise ratio deteriorates after every occasion. The material
of the cylinders is sensitive. Storing, handling or needle tracking problems may lessen replayability.

33. Technology Commercialization Project: Device for Decomposing PVC
This is one of a series of projects completed by Panidea consultants while employed with the IC2 Institute at
The University of Texas at Austin. The program structure was generally six months of technology evaluation,
where the list of options was reduced from several hundred to a viable 12 – 15 technologies selected for
business development. In the second six months, we were responsible for taking the innovation to the
marketplace, identifying key partners, establishing relationships with these organizations and the key staff,
and getting engagement agreements signed by both the company and the innovator to advance the
technology in the marketplace. Given the program structure, these contacts were identified, relationships
established, and agreement signed within the program timeframes.
The key aspect to the process was in the ongoing development of relationships to bring the product to the
marketplace. These contacts validated the technology as well and became customers as part of the process.
A device for decomposing PVC based and other plastic waste materials with high halogen content, comprising
charging, processing, separating and discharging units. A well developed and documented two-step method at
low temperature for the dehalogenation and degradation of the polymer waste into oil, gas and carbon black
form of energy, without any way of the producing any trace of hazardous or inert waste, or demage to the
environment.

34. Technology Commercialization Project: Virtual Colonoscopy
This is one of a series of projects completed by Panidea consultants while employed with the IC2 Institute at
The University of Texas at Austin. The program structure was generally six months of technology evaluation,
where the list of options was reduced from several hundred to a viable 12 – 15 technologies selected for
business development. In the second six months, we were responsible for taking the innovation to the
marketplace, identifying key partners, establishing relationships with these organizations and the key staff,
and getting engagement agreements signed by both the company and the innovator to advance the
technology in the marketplace. Given the program structure, these contacts were identified, relationships
established, and agreement signed within the program timeframes.
The key aspect to the process was in the ongoing development of relationships to bring the product to the
marketplace. These contacts validated the technology as well and became customers as part of the process.
Early detection of colorectal cancer is still a problem. The two most prominent methods for screening
asymptomatic patients are inefficient: Fecal occult blood testing has poor sensitivity for precancerous polyps,
while colonoscopy has failed to gain acceptance among patients. Virtual Colonoscopy facilitates the
computerized examination of the colon. The project aims to implement, test and validate a Virtual
Colonoscopy Application and Screening Protocol suitable for deployment in clinical practice, with appropriate
interfaces to hospital information systems and clinical work-flow.

35. Technology Commercialization Project: Quinazolinone PARP inhibitors
This is one of a series of projects completed by Panidea consultants while employed with the IC2 Institute at
The University of Texas at Austin. The program structure was generally six months of technology evaluation,
where the list of options was reduced from several hundred to a viable 12 – 15 technologies selected for
business development. In the second six months, we were responsible for taking the innovation to the
marketplace, identifying key partners, establishing relationships with these organizations and the key staff,
and getting engagement agreements signed by both the company and the innovator to advance the
technology in the marketplace. Given the program structure, these contacts were identified, relationships
established, and agreement signed within the program timeframes.
The key aspect to the process was in the ongoing development of relationships to bring the product to the
marketplace. These contacts validated the technology as well and became customers as part of the process.
Increased activation of poly(ADP-ribose) polymerase (PARP) enzyme is a crucial step in the development of
oxidative stress induced cell dysfunction and tissue injury. Oxidative stress also plays a pathogenic role in
chronic heart failure and inflammation. It was demonstrated that PARP inhibition can efficiently reduce
oxidative myocardial damage, but little is known about its protective mechanism. We prepared a new
category of PARP inhibitors with no significant toxicity which can be useful for treatment of oxidative stress
and inflammation related diseases.

36. Technology Commercialization Project: Linear Sound Transmission
This is one of a series of projects completed by Panidea consultants while employed with the IC2 Institute at
The University of Texas at Austin. The program structure was generally six months of technology evaluation,
where the list of options was reduced from several hundred to a viable 12 – 15 technologies selected for
business development. In the second six months, we were responsible for taking the innovation to the
marketplace, identifying key partners, establishing relationships with these organizations and the key staff,
and getting engagement agreements signed by both the company and the innovator to advance the
technology in the marketplace. Given the program structure, these contacts were identified, relationships
established, and agreement signed within the program timeframes.
The key aspect to the process was in the ongoing development of relationships to bring the product to the
marketplace. These contacts validated the technology as well and became customers as part of the process.
This is a connecting layout, which is able to reproduce the sound by 20 times higher quality compared to the
currently available High End systems, even in small size closed boxes. The stereophonic sound, which appears
behind the loudspeakers as well, is created by only two loudspeakers. The invention provides a unique
technical solution based on algorithms and methods. The results are proven by measures too. Our system can
be shown everywhere, and patent rights have been applied for them in order to secure exclusive utilization
on a long term.

37. Technology Commercialization Project: Wireless fetal pulse oximeter
This is one of a series of projects completed by Panidea consultants while employed with the IC2 Institute at
The University of Texas at Austin. The program structure was generally six months of technology evaluation,
where the list of options was reduced from several hundred to a viable 12 – 15 technologies selected for
business development. In the second six months, we were responsible for taking the innovation to the
marketplace, identifying key partners, establishing relationships with these organizations and the key staff,
and getting engagement agreements signed by both the company and the innovator to advance the
technology in the marketplace. Given the program structure, these contacts were identified, relationships
established, and agreement signed within the program timeframes.
The key aspect to the process was in the ongoing development of relationships to bring the product to the
marketplace. These contacts validated the technology as well and became customers as part of the process.
We are developing a wireless fetal pulse oximeter, which measures the arterial oxygen saturation of the fetus
during labor and birth. Measuring this parameter can be very useful to prevent birth complication and
eliminate unnecessary Cesarean-sections. Our novel device overcomes the disadvantage of conventional,
catheter-based fetal oximeters that require adjusting the position of the measurement head several times
during labor, and eliminates the need for a connection cable as well as maternal discomfort caused by the
catheter. We are in prototyping stage.

38. Technology Commercialization Project: Electropneumatic actuators
This is one of a series of projects completed by Panidea consultants while employed with the IC2 Institute at
The University of Texas at Austin. The program structure was generally six months of technology evaluation,
where the list of options was reduced from several hundred to a viable 12 – 15 technologies selected for
business development. In the second six months, we were responsible for taking the innovation to the
marketplace, identifying key partners, establishing relationships with these organizations and the key staff,
and getting engagement agreements signed by both the company and the innovator to advance the
technology in the marketplace. Given the program structure, these contacts were identified, relationships
established, and agreement signed within the program timeframes.
The key aspect to the process was in the ongoing development of relationships to bring the product to the
marketplace. These contacts validated the technology as well and became customers as part of the process.
Developing multi-functional linear actuators which involve excursion-sensors.The actuators have low
answering time (about 1 ms) and are able to make big force with good efficiency. Besides, the purpose of the
development is to improve the actuator control (micro-controller combined with PWM amplifier). This makes
possible to control/guide the actuators with the PC on USB channel.

39. Technology Commercialization Project: Pulse Oximeter
This is one of a series of projects completed by Panidea consultants while employed with the IC2 Institute at
The University of Texas at Austin. The program structure was generally six months of technology evaluation,
where the list of options was reduced from several hundred to a viable 12 – 15 technologies selected for
business development. In the second six months, we were responsible for taking the innovation to the
marketplace, identifying key partners, establishing relationships with these organizations and the key staff,
and getting engagement agreements signed by both the company and the innovator to advance the
technology in the marketplace. Given the program structure, these contacts were identified, relationships
established, and agreement signed within the program timeframes.
The key aspect to the process was in the ongoing development of relationships to bring the product to the
marketplace. These contacts validated the technology as well and became customers as part of the process.
The pulse oximeter is a medical device. It determines the oxygenated hemoglobins in the blood. It's principle
based on the red and infrared light absorption characteristics of oxygenated and deoxygenated hemoglobin. It
measures the pulserate too. We would like to manufacture it with memory, USB connectivity to make trends
in time. The stored datas will be helpful to make the right diagnose for a patient.

40. Technology Commercialization Project: Fish Hormone
This is one of a series of projects completed by Panidea consultants while employed with the IC2 Institute at
The University of Texas at Austin. The program structure was generally six months of technology evaluation,
where the list of options was reduced from several hundred to a viable 12 – 15 technologies selected for
business development. In the second six months, we were responsible for taking the innovation to the
marketplace, identifying key partners, establishing relationships with these organizations and the key staff,
and getting engagement agreements signed by both the company and the innovator to advance the
technology in the marketplace. Given the program structure, these contacts were identified, relationships
established, and agreement signed within the program timeframes.
The key aspect to the process was in the ongoing development of relationships to bring the product to the
marketplace. These contacts validated the technology as well and became customers as part of the process.
The technology which is the subject of this report, Fish Hormone, is two preparations of hormone useful for
induced spawning and propagation of fishes. Named Ovopel and Acipel, the products are targeted to carp
producers and sturgeon producers respectively, though they can serve a select few other farm raised fish
breeds as well, including perch and catfish. The primary benefit for both Ovopel and Acipel is improved
quality of spawning, from both quality of fingerlings to quantity of fingerlings, in a timed and predictable
ovulation.
Other benefits include:
· Measured dosage
· Elimination of disease risk
· Low cost of manufacture
All of these benefits combined make Ovopel and Acipel make the offerings potentially more valuable products
than what farmers are using today and primary research resulted in strong interest in the product benefits.
Both Ovopel and Acipel are in production use in Hungary as well as in Poland. The product is made by hand
under the supervision of the inventor and his close associates. Production scalability is questionable and the
product is not protected by a patent. Strong competition exists with many options available to farmers,
including extracting their own spawning aid in the form of pituitary.

41. Technology Commercialization Project: Paper Potty
This is one of a series of projects completed by Panidea consultants while employed with the IC2 Institute at
The University of Texas at Austin. The program structure was generally six months of technology evaluation,
where the list of options was reduced from several hundred to a viable 12 – 15 technologies selected for
business development. In the second six months, we were responsible for taking the innovation to the
marketplace, identifying key partners, establishing relationships with these organizations and the key staff,
and getting engagement agreements signed by both the company and the innovator to advance the
technology in the marketplace. Given the program structure, these contacts were identified, relationships
established, and agreement signed within the program timeframes.
The key aspect to the process was in the ongoing development of relationships to bring the product to the
marketplace. These contacts validated the technology as well and became customers as part of the process.
The PaperPotty technology is a corrugated cardboard pocket sized potty chair for toddlers, PottyFlip. It is a
pre-folded, glued, packaged paperboard potty, folded into the form of a small box, with a waterproof
plastic bag inside. When the potty is opened it forms a potty chair. The technology was invented to provide a
hygienic, easy to carry, quickly usable, disposable and inexpensive solution for parents and their young
children. Children between the ages of 1.5 and 4 years of age are in a transitional stage between using
diapers and toilets and a portable disposable potty offers convenience during these toilet training years.
PottyFlip is an existing product and is currently sold in two convenience store chains (dm-drogeriemarkt,
Rossmann) and in two supermarkets (Cora, Auchan). The technology is protected by various patents
internationally and in the U.S.
Competition in this market is highly fragmented, and while there are competitive products they do not have
significant market power. Options range from simply not having a portable potty solution at all to plastic
travel potties built for parents to take when they travel. There is a significant gap in the landscape for a
product that appeals to small children and is easy and convenient for parents.

42. Technology Commercialization Project: Fingerprint Dusting Composition
This is one of a series of projects completed by Panidea consultants while employed with the IC2 Institute at
The University of Texas at Austin. The program structure was generally six months of technology evaluation,
where the list of options was reduced from several hundred to a viable 12 – 15 technologies selected for
business development. In the second six months, we were responsible for taking the innovation to the
marketplace, identifying key partners, establishing relationships with these organizations and the key staff,
and getting engagement agreements signed by both the company and the innovator to advance the
technology in the marketplace. Given the program structure, these contacts were identified, relationships
established, and agreement signed within the program timeframes.
The key aspect to the process was in the ongoing development of relationships to bring the product to the
marketplace. These contacts validated the technology as well and became customers as part of the process.
This is a provisional release of the Quicklook Report for a Fingerprint Dusting Composition, created by Dr.
G.S. Sodhi. It is incomplete, pending additional information from Prof. Sodhi. When additional information is
available, the Quicklook Report can be completed. The technology which is the subject of this report, as
described by Dr. Sodhi, is a fingerprint composition used to find and reconstitute older prints from various
surfaces. Dr. Sodhi is testing and documenting the effectiveness of his compound as part of an overall process
and expects to complete his evaluation in the next two months. At the completion of his evaluation, he expects
to have a proof of concept of the compound and process which can be used to remove fingerprints which are
more than 48 hours old and have been subjected to adverse conditions. For the purposes of this discussion,
Dr. Sodhi defines adverse conditions as “not in a controlled environment.”, outside a laboratory with
imprecise samples under variable weather conditions. To summarize the fingerprinting process, prints are
left behind by a person on a surface. The prints, whether they be recent or not, can be raised by Dr. Sodhi‟s
compound. The perceived advantage to his compound is his ability to find older prints. After the print has
been left and reconstituted, the police will use powders and dust the print and use tape to raise the print and
remove it from the location for study and analysis by people and computers.

43. Technology Commercialization Project: Optical Cryocooler
This is one of a series of projects completed by Panidea consultants while employed with the IC2 Institute at
The University of Texas at Austin. The program structure was generally six months of technology evaluation,
where the list of options was reduced from several hundred to a viable 12 – 15 technologies selected for
business development. In the second six months, we were responsible for taking the innovation to the
marketplace, identifying key partners, establishing relationships with these organizations and the key staff,
and getting engagement agreements signed by both the company and the innovator to advance the
technology in the marketplace. Given the program structure, these contacts were identified, relationships
established, and agreement signed within the program timeframes.
The key aspect to the process was in the ongoing development of relationships to bring the product to the
marketplace. These contacts validated the technology as well and became customers as part of the process.
The technology which is the subject of this report, Optical Cryocooler, is a dual cooler system comprised of an
optical laser-energy cooler with a secondary thermoelectric cooler powered by fluorescent radiation emitted
during operation. Applications that can use this technology are in the aerospace, medical and electronic
industries where specialized components need to operate at extremely low temperatures.
Existing cryocooler technologies can operate in the 50-150 Kelvin range, but future operations need to extend
lower to the 6-20 Kelvin range. This is difficult with mechanical powered coolers due to excess heat and
vibrations that are given off. The benefit of the Optical Cryocooler is that there are no moving parts and the
captured energy from the initial cooling cycle is used to reduce the temperature more efficiently.
Presently the technology is in a very early development stage. It is designed using an existing Indian
cryocooler patent and incorporating the thermoelectric shielding onto it. Testing has only been performed
with 2W of power due to the collimater limitation to focus the beam. There is support for testing from an
industry leader to develop a working model.

44. Technology Commercialization Project: Mobile Software Platform
This is one of a series of projects completed by Panidea consultants while employed with the IC2 Institute at
The University of Texas at Austin. The program structure was generally six months of technology evaluation,
where the list of options was reduced from several hundred to a viable 12 – 15 technologies selected for
business development. In the second six months, we were responsible for taking the innovation to the
marketplace, identifying key partners, establishing relationships with these organizations and the key staff,
and getting engagement agreements signed by both the company and the innovator to advance the
technology in the marketplace. Given the program structure, these contacts were identified, relationships
established, and agreement signed within the program timeframes.
The key aspect to the process was in the ongoing development of relationships to bring the product to the
marketplace. These contacts validated the technology as well and became customers as part of the process.
The technology reviewed in this document is a software solution that aids in the development and testing of
embedded software systems used on devices like mobile phones, routers, and others semiconductor devices.
At present, the solution is a series of tools that includes the modeling of processors, and the remaining system
components (keyboard, LCD, USB, etc). It also includes verification tools to generate test cases. Future plans
include the ability to generate an entire design that can be exported and executed on a FPGA (field
programmable gate array) type chip. The benefits of this technology are best illustrated by the diagram
below. At present, embedded software design is often delayed or hindered until general availability of the
hardware to test on. By being able to model hardware functionality prior to availability, the development
cycle for a new device can be cut almost in half.

45. Technology Commercialization Project: Fruit Coating
This is one of a series of projects completed by Panidea consultants while employed with the IC2 Institute at
The University of Texas at Austin. The program structure was generally six months of technology evaluation,
where the list of options was reduced from several hundred to a viable 12 – 15 technologies selected for
business development. In the second six months, we were responsible for taking the innovation to the
marketplace, identifying key partners, establishing relationships with these organizations and the key staff,
and getting engagement agreements signed by both the company and the innovator to advance the
technology in the marketplace. Given the program structure, these contacts were identified, relationships
established, and agreement signed within the program timeframes.
The key aspect to the process was in the ongoing development of relationships to bring the product to the
marketplace. These contacts validated the technology as well and became customers as part of the process.
The technology which is the subject of this report, fruit coatings, is a water soluble coating that can extend the
shelf life of fruits and vegetables by up to two weeks without refrigeration. The coated produce retains all of
its natural characteristics and natural water loss is significantly reduced. The coating can be applied
manually, allowing the process to be done in rural areas with limited or no electrical power. One liter of
coating will cover approximately 100 kilograms of fruit.
Although India is the world’s second largest producer of fruits and vegetables, approximately 25% of that
produce spoils and never reaches the consumer resulting in billions of dollars of losses in vegetables alone.
The losses are due to the fact that most fruits are harvested slowly by hand and limited refrigeration facilities
are available for post harvest treatment. By extending the produce’s shelf life, this low cost coating would
allow farmers to expand their market reach significantly. Primarily, it would help give farmers more time to
transport their produce to more distant markets. In addition, by allowing the produce to be stored for a
longer time, the coating would help farmers avoid price fluctuations